Design and Synthesis of a Series of (2R)-N 4-Hydroxy-2-(3-hydroxybenzyl)-N - [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden- 1-yl]butanediamide Derivatives as Potent, Selective, and Orally Bioavailable Aggrecanase Inhibitors

A pharmacophore model of the P1‘ site, specific for aggrecanase, was defined using the specificity studies of the matrix metalloproteinases and the similar biological activity of aggrecanase and MMP-8. Incorporation of the side chain of a tyrosine residue into compound 1 as the P1‘ group provided mo...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 44; no. 21; pp. 3347 - 3350
Main Authors Yao, Wenqing, Wasserman, Zelda R, Chao, Michael, Reddy, Gade, Shi, Eric, Liu, Rui-Qin, Covington, Maryanne B, Arner, Elizabeth C, Pratta, Michael A, Tortorella, Micky, Magolda, Ronald L, Newton, Robert, Qian, MingXin, Ribadeneira, Maria D, Christ, David, Wexler, Ruth R, Decicco, Carl P
Format Journal Article
LanguageEnglish
Published American Chemical Society 11.10.2001
Online AccessGet full text

Cover

Loading…
Abstract A pharmacophore model of the P1‘ site, specific for aggrecanase, was defined using the specificity studies of the matrix metalloproteinases and the similar biological activity of aggrecanase and MMP-8. Incorporation of the side chain of a tyrosine residue into compound 1 as the P1‘ group provided modest selectivity for aggrecanase over MMP-1, -2, and -9. A cis-(1S)(2R)-amino-2-indanol scaffold was incorporated as a tyrosine mimic (P2‘) to conformationally constrain 2. Further optimization resulted in compound 11, a potent, selective, and orally bioavailable inhibitor of aggrecanase.
AbstractList A pharmacophore model of the P1‘ site, specific for aggrecanase, was defined using the specificity studies of the matrix metalloproteinases and the similar biological activity of aggrecanase and MMP-8. Incorporation of the side chain of a tyrosine residue into compound 1 as the P1‘ group provided modest selectivity for aggrecanase over MMP-1, -2, and -9. A cis-(1S)(2R)-amino-2-indanol scaffold was incorporated as a tyrosine mimic (P2‘) to conformationally constrain 2. Further optimization resulted in compound 11, a potent, selective, and orally bioavailable inhibitor of aggrecanase.
Author Reddy, Gade
Pratta, Michael A
Liu, Rui-Qin
Newton, Robert
Arner, Elizabeth C
Chao, Michael
Christ, David
Yao, Wenqing
Qian, MingXin
Decicco, Carl P
Wasserman, Zelda R
Covington, Maryanne B
Magolda, Ronald L
Wexler, Ruth R
Ribadeneira, Maria D
Tortorella, Micky
Shi, Eric
Author_xml – sequence: 1
  givenname: Wenqing
  surname: Yao
  fullname: Yao, Wenqing
– sequence: 2
  givenname: Zelda R
  surname: Wasserman
  fullname: Wasserman, Zelda R
– sequence: 3
  givenname: Michael
  surname: Chao
  fullname: Chao, Michael
– sequence: 4
  givenname: Gade
  surname: Reddy
  fullname: Reddy, Gade
– sequence: 5
  givenname: Eric
  surname: Shi
  fullname: Shi, Eric
– sequence: 6
  givenname: Rui-Qin
  surname: Liu
  fullname: Liu, Rui-Qin
– sequence: 7
  givenname: Maryanne B
  surname: Covington
  fullname: Covington, Maryanne B
– sequence: 8
  givenname: Elizabeth C
  surname: Arner
  fullname: Arner, Elizabeth C
– sequence: 9
  givenname: Michael A
  surname: Pratta
  fullname: Pratta, Michael A
– sequence: 10
  givenname: Micky
  surname: Tortorella
  fullname: Tortorella, Micky
– sequence: 11
  givenname: Ronald L
  surname: Magolda
  fullname: Magolda, Ronald L
– sequence: 12
  givenname: Robert
  surname: Newton
  fullname: Newton, Robert
– sequence: 13
  givenname: MingXin
  surname: Qian
  fullname: Qian, MingXin
– sequence: 14
  givenname: Maria D
  surname: Ribadeneira
  fullname: Ribadeneira, Maria D
– sequence: 15
  givenname: David
  surname: Christ
  fullname: Christ, David
– sequence: 16
  givenname: Ruth R
  surname: Wexler
  fullname: Wexler, Ruth R
– sequence: 17
  givenname: Carl P
  surname: Decicco
  fullname: Decicco, Carl P
BookMark eNptUV1r20AQPEoKsdM-5B_cS8EGbXpfsuzHNF8OhKTU7VMpYqVb2WfkU7hTTJR_mn8T2W77lKfd2Rl2BmbIjnzjibFTKc6kUPLreiNkmmpdfmADmSoBZirMERsIoRSoidLHbBjjWgihpdID9npJ0S09R2_5ovPtqoeRNxVHvqDgaL-P1I8x3HMD886G5rkDBSMNqwMoyL909Y4H_nskF8lOrP6xoBIN1u0RyDk4b8kDl9DVf4qnFj1ZhxtniV_2dlts3bb3xMi_Ny35NulT1FTursk-40PAuu74N9fgFl2NRU38fLkMVKLHSPzWr1zh2ibET-xjhXWkz3_nCft1ffXzYg53Dze3F-d3gFKYErDIRCZTm2GPrc7QVNZURlezSiltlZimcqZLFMbOCkmTqdSkCpwYmWZEYqZP2PjwtwxNjIGq_DG4DYYulyLfdZL_76TXfjlosYz5unkKvk_2ju4NYeaL5Q
CitedBy_id crossref_primary_10_1016_j_bmcl_2007_07_048
crossref_primary_10_1021_acsptsci_2c00023
crossref_primary_10_1046_j_1432_1033_2003_03607_x
crossref_primary_10_1016_j_bbapap_2011_06_020
crossref_primary_10_1038_nmat2116
crossref_primary_10_1186_s12964_019_0443_2
crossref_primary_10_1172_JCI30765
crossref_primary_10_1021_jm101609j
crossref_primary_10_1002_art_20101
crossref_primary_10_1074_jbc_M303737200
crossref_primary_10_1016_j_ejmech_2012_12_058
crossref_primary_10_2106_JBJS_F_01437
crossref_primary_10_1016_j_bmcl_2005_10_001
crossref_primary_10_1016_j_ab_2007_09_014
crossref_primary_10_1016_j_bmcl_2006_12_027
crossref_primary_10_1016_j_matbio_2015_01_014
crossref_primary_10_1002_fsn3_601
crossref_primary_10_1002_art_10726
crossref_primary_10_1016_S0306_4522_02_00347_0
crossref_primary_10_1074_jbc_M200431200
crossref_primary_10_1002_ddr_20166
crossref_primary_10_1016_j_matbio_2005_12_003
crossref_primary_10_1007_s40520_018_0953_6
crossref_primary_10_1016_j_joca_2006_01_012
crossref_primary_10_1074_jbc_M109_029116
crossref_primary_10_1021_ol102756m
crossref_primary_10_1080_10799893_2019_1710848
crossref_primary_10_1016_S0960_894X_01_00704_1
crossref_primary_10_1016_j_tetasy_2003_08_040
crossref_primary_10_2116_analsci_21_61
crossref_primary_10_1002_cmdc_200900523
crossref_primary_10_1016_j_ejmech_2013_08_027
crossref_primary_10_1016_S0960_894X_03_00124_0
crossref_primary_10_1016_j_bmcl_2006_12_020
crossref_primary_10_1016_j_rechem_2023_101135
crossref_primary_10_1021_acs_jmedchem_2c01177
crossref_primary_10_1186_s13075_014_0429_9
crossref_primary_10_1002_jcb_23298
crossref_primary_10_1517_14728222_7_1_19
crossref_primary_10_1002_minf_201100131
crossref_primary_10_1016_j_bmcl_2011_09_036
crossref_primary_10_1021_cr050970a
crossref_primary_10_1016_j_bmc_2008_08_058
crossref_primary_10_1016_j_joca_2008_10_005
crossref_primary_10_1002_ejoc_202301143
crossref_primary_10_1016_j_bmcl_2009_02_024
crossref_primary_10_1016_j_bmcl_2011_06_009
crossref_primary_10_4155_fmc_14_84
Cites_doi 10.2174/1381612805666230111211438
10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R
10.1016/S0021-9258(18)48387-1
10.1021/jo00036a004
10.1021/cr9804543
10.1074/jbc.272.14.9294
10.2106/00004623-197052030-00002
10.1110/ps.48401
10.1016/S0021-9258(18)41799-1
10.1021/jm00014a010
10.1111/j.1749-6632.1999.tb07676.x
10.1016/S0021-9258(18)45559-7
10.1016/S0968-0896(97)00028-X
10.1074/jbc.274.10.6594
10.1074/jbc.M001065200
10.1016/S0960-894X(01)00137-8
10.1126/science.284.5420.1664
10.1074/jbc.270.6.2550
10.1021/jm960871c
10.1016/0014-5793(95)01539-6
10.1021/jm00047a001
10.1042/bj2950273
10.1042/bj3040347
ContentType Journal Article
Copyright Copyright © 2001 American Chemical Society
Copyright_xml – notice: Copyright © 2001 American Chemical Society
DBID AAYXX
CITATION
DOI 10.1021/jm015533c
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1520-4804
EndPage 3350
ExternalDocumentID 10_1021_jm015533c
b586369922
GroupedDBID -
.K2
3EH
53G
55A
5GY
5RE
5VS
7~N
9M8
AABXI
ABFLS
ABMVS
ABOCM
ABPTK
ABUCX
ACGFS
ACJ
ACS
ADKFC
AEESW
AENEX
AFEFF
AFFNX
ALMA_UNASSIGNED_HOLDINGS
ANTXH
AQSVZ
BAANH
CS3
DU5
EBS
ED
ED~
EJD
F5P
GJ
GNL
IH9
IHE
JG
JG~
K2
L7B
LG6
MVM
NHB
P2P
ROL
TN5
UI2
VF5
VG9
W1F
WH7
X
XFK
YZZ
ZE2
ZGI
ZY4
---
-~X
.GJ
AAHBH
AAYOK
AAYXX
ABJNI
ABQRX
ABTAH
ACGFO
ADHLV
AGXLV
AHGAQ
CITATION
CUPRZ
GGK
IH2
XSW
YQT
ID FETCH-LOGICAL-a104c-ab70715d7aa10d37a4fd4f43f9f223d2085193ca04d9b1e6813e2ba64157ee093
IEDL.DBID ACS
ISSN 0022-2623
IngestDate Fri Aug 23 02:29:23 EDT 2024
Thu Aug 27 13:42:21 EDT 2020
IsPeerReviewed true
IsScholarly true
Issue 21
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a104c-ab70715d7aa10d37a4fd4f43f9f223d2085193ca04d9b1e6813e2ba64157ee093
PageCount 4
ParticipantIDs crossref_primary_10_1021_jm015533c
acs_journals_10_1021_jm015533c
ProviderPackageCode JG~
55A
AABXI
GNL
VF5
7~N
ACJ
VG9
W1F
ANTXH
ACS
AEESW
AFEFF
.K2
ABMVS
ABUCX
IH9
BAANH
AQSVZ
ED~
UI2
PublicationCentury 2000
PublicationDate 20011011
PublicationDateYYYYMMDD 2001-10-11
PublicationDate_xml – month: 10
  year: 2001
  text: 20011011
  day: 11
PublicationDecade 2000
PublicationTitle Journal of medicinal chemistry
PublicationTitleAlternate J. Med. Chem
PublicationYear 2001
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References Dunten P. (jm015533cb00019/jm015533cb00019_1) 2001; 10
Dorsey B. D. (jm015533cb00014/jm015533cb00014_1) 1994; 37
Sandy J. D. (jm015533cb00004/jm015533cb00004_3) 1991; 266
Fosang A. J. (jm015533cb00002/jm015533cb00002_4) 1996; 380
Moy F. J. (jm015533cb00019/jm015533cb00019_3) 2000; 302
Van Meurs B. J. (jm015533cb00004/jm015533cb00004_5) 1999; 42
Fields G. B. (jm015533cb00011/jm015533cb00011_1) 1987; 262
Askin D. (jm015533cb00023/jm015533cb00023_1) 1992; 57
Zhang D. (jm015533cb00015/jm015533cb00015_1) 1994; 91
Compound (jm015533cb00008/jm015533cb00008_1) 1986
Arner E. C. (jm015533cb00004/jm015533cb00004_4) 1999; 274
Tortorella M. (jm015533cb00018/jm015533cb00018_1) 2000; 275
Xue C.-B. (jm015533cb00018/jm015533cb00018_2) 1998; 41
Luty B. A. (jm015533cb00017/jm015533cb00017_1) 1995; 16
Whittaker M. (jm015533cb00007/jm015533cb00007_1) 1999; 99
Mankin H. J. (jm015533cb00001/jm015533cb00001_1) 1970; 52
Tortorella M. D. (jm015533cb00003/jm015533cb00003_1) 1999; 284
Pikul S. (jm015533cb00019/jm015533cb00019_2) 2001; 11
Fosang A. J. (jm015533cb00009/jm015533cb00009_1) 1994; 304
Gowravaram M. R. (jm015533cb00013/jm015533cb00013_1) 1995; 38
Miller J. A. (jm015533cb00018/jm015533cb00018_3) 1998
Nagase H. (jm015533cb00010/jm015533cb00010_1) 1996; 40
Lark W. (jm015533cb00004/jm015533cb00004_6) 1995; 270
Baenteli R. (jm015533cb00022/jm015533cb00022_1) 1999; 40
Lohamnder L. S. (jm015533cb00004/jm015533cb00004_2) 1993; 36
Gomis-Ruth F. X. (jm015533cb00016/jm015533cb00016_1) 1994; 239
Fosang A. J. (jm015533cb00002/jm015533cb00002_1) 1992; 267
Fosang A. J. (jm015533cb00002/jm015533cb00002_3) 1993; 295
Hirayama R. (jm015533cb00020/jm015533cb00020_1) 1997; 5
MacPherson L. J. (jm015533cb00021/jm015533cb00021_1) 1997; 40
Flannery C. R. (jm015533cb00002/jm015533cb00002_2) 1992; 267
Tortorella M. (jm015533cb00012/jm015533cb00012_1) 2000; 275
Arner E. C. (jm015533cb00004/jm015533cb00004_1) 1998
Arner E. C. (jm015533cb00005/jm015533cb00005_1) 1999; 878
Arner C. (jm015533cb00009/jm015533cb00009_2) 1997; 272
Michaelides M. R. (jm015533cb00006/jm015533cb00006_1) 1999; 5
References_xml – volume: 5
  start-page: 819
  year: 1999
  ident: jm015533cb00006/jm015533cb00006_1
  publication-title: Curr. Pharm. Des.
  doi: 10.2174/1381612805666230111211438
  contributor:
    fullname: Michaelides M. R.
– volume: 40
  start-page: 416
  year: 1996
  ident: jm015533cb00010/jm015533cb00010_1
  publication-title: Biopolymers
  doi: 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R
  contributor:
    fullname: Nagase H.
– volume: 40
  start-page: 2112
  year: 1999
  ident: jm015533cb00022/jm015533cb00022_1
  publication-title: Tetrahedron Lett.
  contributor:
    fullname: Baenteli R.
– volume: 267
  start-page: 1014
  year: 1992
  ident: jm015533cb00002/jm015533cb00002_2
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)48387-1
  contributor:
    fullname: Flannery C. R.
– volume-title: Cytokine-induced cartilage proteoglycan degradation is meadiated by aggrecanase Osteoarthritis Cartilage
  year: 1998
  ident: jm015533cb00004/jm015533cb00004_1
  contributor:
    fullname: Arner E. C.
– volume: 57
  start-page: 2773
  year: 1992
  ident: jm015533cb00023/jm015533cb00023_1
  publication-title: J. Org. Chem.
  doi: 10.1021/jo00036a004
  contributor:
    fullname: Askin D.
– volume: 99
  start-page: 2776
  year: 1999
  ident: jm015533cb00007/jm015533cb00007_1
  publication-title: Chem. Rev.
  doi: 10.1021/cr9804543
  contributor:
    fullname: Whittaker M.
– volume: 272
  start-page: 9299
  year: 1997
  ident: jm015533cb00009/jm015533cb00009_2
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.272.14.9294
  contributor:
    fullname: Arner C.
– volume: 52
  start-page: 434
  year: 1970
  ident: jm015533cb00001/jm015533cb00001_1
  publication-title: J. Bone Joint Surg
  doi: 10.2106/00004623-197052030-00002
  contributor:
    fullname: Mankin H. J.
– volume: 10
  start-page: 926
  year: 2001
  ident: jm015533cb00019/jm015533cb00019_1
  publication-title: Protein Sci.
  doi: 10.1110/ps.48401
  contributor:
    fullname: Dunten P.
– volume: 302
  start-page: 89
  year: 2000
  ident: jm015533cb00019/jm015533cb00019_3
  publication-title: J. Mol. Biol.
  contributor:
    fullname: Moy F. J.
– volume: 239
  start-page: 544
  year: 1994
  ident: jm015533cb00016/jm015533cb00016_1
  publication-title: J. Mol. Biol.
  contributor:
    fullname: Gomis-Ruth F. X.
– volume: 267
  start-page: 19474
  year: 1992
  ident: jm015533cb00002/jm015533cb00002_1
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)41799-1
  contributor:
    fullname: Fosang A. J.
– volume: 275
  start-page: 25797
  year: 2000
  ident: jm015533cb00012/jm015533cb00012_1
  publication-title: J. Biol. Chem
  contributor:
    fullname: Tortorella M.
– volume: 38
  start-page: 2581
  year: 1995
  ident: jm015533cb00013/jm015533cb00013_1
  publication-title: J. Med. Chem.
  doi: 10.1021/jm00014a010
  contributor:
    fullname: Gowravaram M. R.
– volume-title: Assays and peptide substrate for determining aggrecan-degrading metalloprotease activity. WO 0005256
  year: 1998
  ident: jm015533cb00018/jm015533cb00018_3
  contributor:
    fullname: Miller J. A.
– volume: 878
  start-page: 107
  year: 1999
  ident: jm015533cb00005/jm015533cb00005_1
  publication-title: N. Y. Acad. Sci.
  doi: 10.1111/j.1749-6632.1999.tb07676.x
  contributor:
    fullname: Arner E. C.
– volume: 42
  start-page: 1139
  year: 1999
  ident: jm015533cb00004/jm015533cb00004_5
  publication-title: Arthritis Rheum.
  contributor:
    fullname: Van Meurs B. J.
– volume: 262
  year: 1987
  ident: jm015533cb00011/jm015533cb00011_1
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)45559-7
  contributor:
    fullname: Fields G. B.
– volume: 5
  start-page: 778
  year: 1997
  ident: jm015533cb00020/jm015533cb00020_1
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/S0968-0896(97)00028-X
  contributor:
    fullname: Hirayama R.
– volume: 274
  start-page: 6601
  year: 1999
  ident: jm015533cb00004/jm015533cb00004_4
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.274.10.6594
  contributor:
    fullname: Arner E. C.
– volume: 275
  start-page: 25791
  year: 2000
  ident: jm015533cb00018/jm015533cb00018_1
  publication-title: J. Biol. Chem
  doi: 10.1074/jbc.M001065200
  contributor:
    fullname: Tortorella M.
– volume: 11
  start-page: 13
  year: 2001
  ident: jm015533cb00019/jm015533cb00019_2
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/S0960-894X(01)00137-8
  contributor:
    fullname: Pikul S.
– volume: 284
  start-page: 1666
  year: 1999
  ident: jm015533cb00003/jm015533cb00003_1
  publication-title: Science
  doi: 10.1126/science.284.5420.1664
  contributor:
    fullname: Tortorella M. D.
– volume: 270
  start-page: 6
  year: 1995
  ident: jm015533cb00004/jm015533cb00004_6
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.270.6.2550
  contributor:
    fullname: Lark W.
– volume: 40
  start-page: 2532
  year: 1997
  ident: jm015533cb00021/jm015533cb00021_1
  publication-title: J. Med. Chem.
  doi: 10.1021/jm960871c
  contributor:
    fullname: MacPherson L. J.
– volume: 380
  start-page: 20
  year: 1996
  ident: jm015533cb00002/jm015533cb00002_4
  publication-title: FEBS Lett.
  doi: 10.1016/0014-5793(95)01539-6
  contributor:
    fullname: Fosang A. J.
– volume: 266
  start-page: 205
  year: 1991
  ident: jm015533cb00004/jm015533cb00004_3
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Sandy J. D.
– volume: 37
  start-page: 51
  year: 1994
  ident: jm015533cb00014/jm015533cb00014_1
  publication-title: J. Med. Chem.
  doi: 10.1021/jm00047a001
  contributor:
    fullname: Dorsey B. D.
– volume: 295
  start-page: 276
  year: 1993
  ident: jm015533cb00002/jm015533cb00002_3
  publication-title: Biochem. J.
  doi: 10.1042/bj2950273
  contributor:
    fullname: Fosang A. J.
– volume: 16
  start-page: 464
  year: 1995
  ident: jm015533cb00017/jm015533cb00017_1
  publication-title: J. Comput. Chem.
  contributor:
    fullname: Luty B. A.
– volume: 304
  start-page: 351
  year: 1994
  ident: jm015533cb00009/jm015533cb00009_1
  publication-title: Biochem. J.
  doi: 10.1042/bj3040347
  contributor:
    fullname: Fosang A. J.
– volume-title: Patent 4,599,361
  year: 1986
  ident: jm015533cb00008/jm015533cb00008_1
  contributor:
    fullname: Compound
– volume: 41
  start-page: 1748
  year: 1998
  ident: jm015533cb00018/jm015533cb00018_2
  publication-title: J. Med. Chem.
  contributor:
    fullname: Xue C.-B.
– volume: 91
  start-page: 8451
  year: 1994
  ident: jm015533cb00015/jm015533cb00015_1
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  contributor:
    fullname: Zhang D.
– volume: 36
  start-page: 1222
  year: 1993
  ident: jm015533cb00004/jm015533cb00004_2
  publication-title: Arthritis Rheum.
  contributor:
    fullname: Lohamnder L. S.
SSID ssj0003123
Score 1.6923633
Snippet A pharmacophore model of the P1‘ site, specific for aggrecanase, was defined using the specificity studies of the matrix metalloproteinases and the similar...
SourceID crossref
acs
SourceType Aggregation Database
Publisher
StartPage 3347
Title Design and Synthesis of a Series of (2R)-N 4-Hydroxy-2-(3-hydroxybenzyl)-N - [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden- 1-yl]butanediamide Derivatives as Potent, Selective, and Orally Bioavailable Aggrecanase Inhibitors
URI http://dx.doi.org/10.1021/jm015533c
Volume 44
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1bb9MwFLbGeIAXGAPEuExHgKYixZsvuT52LVNBYlR0kyYhVNmxswWyFC3tpOyf7t_sOGlYpQl4ixXHOZJP_H2Oz_kOIe8R8gRXKqHGRpKiUzCquOU0CnRklVapNO5E98thODr2P58EJ2vk3V9O8AXf-3ne1LaR6T1yXyAeuh1WfzD5s9xKLmQnCS4QzDv5oNVHHfSk1Qr0rGDIwWMy7DJx2tCRX7uLud5Nr-4KM_7LvA3yaMkhod9O-hOyZstN8mDQlW7bJDvjVpC69uDoNr-q8mAHxrdS1fVTcj1sAjhAlQYmdYlksMormGWgwP02s811T3z7QA_Bp6PaOMupoD1Jz9qGtuVVXbj7FL73-MRznUV3lwpPUpM3LcpH1GkzlhQ4rYsfeoG81OWtnOfGwhBfd9mIkFegKhjPkMvPPbSiaFdkr7Hx64Uqihr285m6VHnh0r6gf3qKq7YqEY7hU3mW69wVEHpGjg8-Hg1GdFnsAX2D-SlVOkK2E5hIYdvISPmZ8TNfZkmGDMa4UqLINVPFfJNobsOYSyu0CpGARNayRD4n6-WstC8IRH7MwowFcZimfsCYZjoQcZxlmcDBgmSLbKM3TJcfazVtzuEF7oO6qdwibztHmf5uRT_udnr5v1FekYdNwJoLf-Gvyfr8YmHfIIOZ6-3Gg28A6lnpEw
link.rule.ids 315,786,790,2782,27107,27955,27956,57091,57141
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZgPIwXLgPEBgwLoalI8fAl18fRMWWwlYp20qQJVXbsbBlZipZ2UvZP-TccOw2t4AHeYsVxTuQTf1_ic76D0FuAPM6kTIg2kSDgFJRIZhiJAhUZqWQmtN3RPR6E6Yn_6TQ4Xcjk2FwYMKKGkWq3ib9UF2DvL69ciRuR3UX3gghQztKg_uj3qisYF50yOAdM71SEVi-1CJTVKwi0AiUHD9uaRM4IF0HyfXc-U7vZ7R_6jP9n5SP0YMEo8V7rAo_RHVNtoPV-V8htA-0MW3nqxsPjZbZV7eEdPFwKVzdP0M99F86BZaXxqKmAGtZFjac5ltj-RDPuuMe_viMD7JO00fYBCCc9QS7ahjLVbVPa8wSf9djIs515d5ZwTxBduBZhKbFKjRXBjDTlNzUHlmqzWK4KbfA-3O7GSZLXWNZ4OAVmP_PAirJdnz1n45drWZYN_lBM5Y0sSpsEhvfOz2ENlxWAMz6sLgpV2HJCT9HJwcdxPyWL0g_gKdTPiFQRcJ9ARxLaWkTSz7Wf-yJPcuAz2hYWBeaZSerrRDETxkwYrmQIdCQyhibiGVqrppV5jnDkxzTMaRCHWeYHlCqqAh7HeZ5zGCxINtE2zORk8erWE7crz-GrqJvKTfSm85fJj1YC5O9OW_8a5TVaT8fHR5Ojw8HnF-i-C2WzgTHsJVqbXc_NK-A2M7XtnPoXrgDxfg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZgSMALlwFiXIaF0FSkeMR2ro-lpeq4dBXdpEkIVXZsb4EsnZZ2UvZP-TccO8lWwQO8xbLjnMjHPp_tc76D0BsweYwKkRKlY05AKXwiqKYkDmWshRQZV_ZG98skGh8GH4_Co3ajaGNhQIgKeqrcJb6d1WfKtAwD9N2PU5fmhmc30a0wpoGdiP3B7Grl5ZTxjh2cgV3vmITWX7VWKKvWrNCaORndR_tXgjgvkp-7q6XczS7_4Gj8f0kfoHstssT9RhUeohu63ER3Bl1Ct020M21oqmsPH1xHXVUe3sHTawLr-hH6NXRuHViUCs_qEiBilVd4YbDA9jBNu-ce-_qWTHBAxrWyP0EY6XFy0hSkLi_rwtYT_K1HZ55tzLpawjxOVO5KhI6JZWwsCaakLr7LFaBVG81ymiuNh_C5C0dNXmFR4ekCEP7SAymKZp32nIz756Ioavw-X4gLkRc2GAz3j49hLRclGGm8V57kMrdphR6jw9GHg8GYtCkgQGP8ICNCxoCBQhULKCsei8CowATcpAZwjbIJRgGBZsIPVCqpjhLKNZMiAlgSa-2n_AnaKBelfopwHCR-ZPwwibIsCH1f-jJkSWKMYdBZmG6hbRjNeTuFq7m7nWewO-qGcgu97nRmftZQgfzd6Nm_enmFbk-Ho_nnvcmn5-iu82iz_jH0BdpYnq_0S4A4S7nt9Po3i3fz-A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Design+and+Synthesis+of+a+Series+of+%282+R+%29-+N+4+-Hydroxy-2-%283-hydroxybenzyl%29-+N+-+%5B%281+S+%2C2+R+%29-2-hydroxy-2%2C3-dihydro-1+H+-inden-+1-yl%5Dbutanediamide+Derivatives+as+Potent%2C+Selective%2C+and+Orally+Bioavailable+Aggrecanase+Inhibitors&rft.jtitle=Journal+of+medicinal+chemistry&rft.au=Yao%2C+Wenqing&rft.au=Wasserman%2C+Zelda+R.&rft.au=Chao%2C+Michael&rft.au=Reddy%2C+Gade&rft.date=2001-10-11&rft.issn=0022-2623&rft.eissn=1520-4804&rft.volume=44&rft.issue=21&rft.spage=3347&rft.epage=3350&rft_id=info:doi/10.1021%2Fjm015533c&rft.externalDBID=n%2Fa&rft.externalDocID=10_1021_jm015533c
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2623&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2623&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2623&client=summon